Evidence map›Paper›PMID 36155363›Full record

ArticleMicrobes and environments2022

Supplemental Clostridium butyricum MIYAIRI 588 Affects Intestinal Bacterial Composition of Finishing Pigs.

Maki Hirata, Miki Matsuoka, Takuma Hashimoto, Takamichi Oura, Yo Ohnuki, Chika Yoshida, Ayaka Minemura, Daiki Miura, Kentaro Oka, Motomichi Takahashi and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Microbes and environments, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Microorganisms · 2025
    Article
  2. Microbiology spectrum · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Maki HirataBio-Innovation Research Center, Tokushima University.
Miki MatsuokaBio-Innovation Research Center, Tokushima University.
Takuma HashimotoFaculty of Bioscience and Bioindustry, Tokushima University.
Takamichi OuraFaculty of Bioscience and Bioindustry, Tokushima University.
Yo OhnukiBio-Innovation Research Center, Tokushima University.
Chika YoshidaBio-Innovation Research Center, Tokushima University.
Ayaka MinemuraR&D Division, Miyarisan Pharmaceutical Co., Ltd.
Daiki MiuraR&D Division, Miyarisan Pharmaceutical Co., Ltd.
Kentaro OkaR&D Division, Miyarisan Pharmaceutical Co., Ltd.
Motomichi TakahashiR&D Division, Miyarisan Pharmaceutical Co., Ltd.
Fumiki MorimatsuBio-Innovation Research Center, Tokushima University.
Innovation Research Center · USTokushima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Animal gastrointestinal tracts are populated by highly diverse and complex microbiotas. The gut microbiota influences the bioavailability of dietary components and is closely associated with physiological processes in the host. Clostridium butyricum reportedly improves growth performance and affects the gut microbiota and immune functions in post-weaning piglets. However, the effects of C. butyricum on finishing pigs remain unclear. Therefore, we herein investigated the effects of C. butyricum MIYAIRI 588 (CBM588) on the gut microbiota of finishing pigs. 16S rRNA gene sequencing was performed using fecal samples and ileal, cecal, and colonic contents collected after slaughtering. The α-diversity of the small intestinal microbiota was lower than that of the large intestinal microbiota, whereas β-diversity showed different patterns depending on sample collection sites. The administration of CBM588 did not significantly affect the α- or β-diversity of the microbiotas of fecal and intestinal content samples regardless of the collection site. However, a linear discriminant ana-lysis Effect Size revealed that the relative abundance of Lactobacillaceae at the family level, Bifidobacterium at the order level, and Lactobacillus ruminis and Bifidobacterium pseudolongum at the species level were higher in the fecal samples and cecal and colonic contents of the treatment group than in those of the control group. Therefore, the administration of CBM588 to finishing pigs affected the composition of the gut microbiota and increased the abundance of bacteria that are beneficial to the host. These results provide important insights into the effects of probiotic administration on relatively stable gut microbial ecosystems.

Indexed as

Clostridium butyricumGastrointestinal MicrobiomeMicrobiotaProbioticsAnimalsRNA, Ribosomal, 16SSwineRNA, Ribosomal, 16SClostridium butyricumgut microbiotapigprobiotics

Identifiers

PMID36155363
PMCPMC9530721
OpenAlexW4296917222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.